CHICAGO--(BUSINESS WIRE)--TVT2019 – Structural Heart Summit --Materialise (NASDAQ:MTLS), a global 3D printing software and solutions company, has received FDA clearance for its Mimics Enlight ...
With more than 25 years of industry expertise, Materialise's software and 3D printing service solutions provide the backbone of end-to-end medical 3D printing. These solutions are reinventing ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results